judis ( Uploaded on: 26/08/2025 07:59:11 pm )
ingredients called excipients are used in all drugs to produce a
pharmaceutical formulation that ... animals through one or more modes of drug delivery/administration.
Because these excipients do not have a direct pharmacological action,
they are often referred
formulation of the claimed invention not only because different
classes of excipients are used, but also because IN 2243/MUM/2014 requires ... excipients that remain as insoluble solid particles. By contrast, the
EC formulation does not include any insoluble solid particles and, therefore,
does not require suspending
salts thereof present in suitable weight ratio, along with
pharmaceutically acceptable excipients. The said synergistic nutritional
composition is useful for treating diseases or disorders related ... weight ratio of 1:0.05 to 1 :2 along with
pharmaceutically acceptable excipients, wherein the inosine
monophosphate disodium salt hydrate is present in a range
effective amount of zinc oxide and at least one agrochemically
acceptable excipient (Surfactant), having a particle size of 0.1 micron to 50
microns, which provides ... Claim 11)
(iii) 3.8% Excipient (surfactant) (which falls within the range of 3% to
65%)
(iv) the product is in the form of broadcast granules
length amongst the mixtures of
compositions cited in 29 different forms of excipients are esters made from
C16 acids. However, document D3 was in fact ... length amongst the mixtures of compositions cited
in 29 different forms of excipients are esters IP made from C16
acids. The applicant further argued that
product patent which relates to an aqueous
pharmaceutical formulation comprising Pertuzumab and excipients
such as sucrose, histidine acetate buffer, polysorbate such that
combination of known substances, 'Clodinafop-
Propargyl and Metribuzin', along with excipients, which amounts to a mere
admixture with no synergistic effect or enhanced ... pigment' is merely an optional 'adjuvant/ excipient' and does not constitute
an essential element of the invention.
Signature Not Verified
Digitally Signed
Diafenthiuron (25% to
55%) and one or more inactive excipients.
CS(COMM) 1205/2025 Page 4 of 25
This is a digitally signed order ... with
Magnesium Aluminium Silicate and Acrylic polymer;
c) one or more inactive excipients selected from the group consisting of
antifreezing agent, anti-foaming agent, suspending
chemical characterization of the
API procured from different suppliers.
b) API - Excipient Compatibility studies: Examine the interaction
between the API and the excipients (inactive ingredients ... Reference Product.
d) Formulation Development: Involves selection and optimisation of
excipients and prototype development. Process involves
permutation and combination of different excipients and drug
substance
chemical characterization of the
API procured from different suppliers.
b) API - Excipient Compatibility studies: Examine the interaction
between the API and the excipients (inactive ingredients ... Reference Product.
d) Formulation Development: Involves selection and optimisation of
excipients and prototype development. Process involves
permutation and combination of different excipients and drug
substance
